As cited by the research report titled ‘United States Shingles Vaccine Market - Growth, Demand, Trends, Opportunity, Forecasts (2020 - 2027)’, available with MarketStudyReport, United States shingles vaccine market is projected to expand significantly over 2021-2027, amassing USD 3.7 billion by the end of the forecast duration.
 

Increasing prevalence of shingles coupled with growing geriatric population are major factors driving United States shingles vaccine market growth.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2890190/
 

Increasing investments in research and development along with launch of advanced products are augmenting the market demand. Moreover, growing government initiatives and rising health awareness are positively swaying the industry dynamics.
 

For the record, shingles are also called as herpes zoster and is a chronic disease that is caused by the varicella-zoster virus which also causes chickenpox. Shingles can result into painful rashes on the skin and extreme nerve pain that may last for over a month or even for years after the rash is gone.
 

Shingles vaccine is made from a weakened form of chickenpox virus to help the body’s immune system in fighting the disease. This vaccine is known to reduce the risk of developing shingles by around 50% and long-term nerve injury by nearly 65%.
 

Speaking of the negatives, high cost of shingle vaccine is likely to hinder the market progression over the assessment period.
 

Based on product type, United Sates shingles vaccine industry is segmented into live and attenuated vaccines. Among these, live vaccines segment is likely to witness lucrative growth over the projected timeline.
 

Considering end user range, the marketplace is categorized into hospitals, clinics, and others. Among these, hospitals segment is poised to showcase significant growth over the estimated timeframe.
 

Prominent players influencing the industry dynamics are GlaxoSmithKline plc, Vaccitech plc, GeneOne Life Science Inc., and Curevo Vaccine.
 

The report examines the detailed profiles of these leading players with information on their businesses, vaccines portfolios of the companies, along with the latest developments.